Historical note and terminology
Topiramate is a monosaccharide derivative with a sulfamate functionality. It has multiple putative mechanisms of action. It was developed as an antiepileptic as McN-4853 and showed effectiveness against maximum electroshock in rats with a potency equal to that of phenytoin. Topiramate was commercialized and has been available in the United Kingdom since mid-1995. The United States Food and Drug Administration approved it in 1997.
The content you are trying to view is available only to logged in, current MedLink Neurology subscribers.
If you are a subscriber, please log in.
If you are a former subscriber or have registered before, please log in first and then click select a Service Plan or contact Subscriber Services. Site license users, click the Site License Acces link on the Homepage at an authorized computer.